Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Quipt Home Medical's average EBITDA Per Share Growth Rate was -2.40% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 13.00% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 24.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Quipt Home Medical was 79.20% per year. The lowest was -152.90% per year. And the median was 19.80% per year.
Quipt Home Medical (NAS:QIPT) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Quipt Home Medical 3-Year EBITDA Growth Rate Related Terms
QIPT vs ACH, EDAP, YI: 3-Year EBITDA Growth Rate Comparison
For the Medical Distribution subindustry, Quipt Home Medical's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quipt Home Medical 3-Year EBITDA Growth Rate vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Quipt Home Medical's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Quipt Home Medical's 3-Year EBITDA Growth Rate falls into.
Quipt Home Medical 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 13.00% mean?
Quipt Home Medical (QIPT) has a 3-Year EBITDA Growth Rate of 13.00% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Quipt Home Medical and its competitors. This is 34% below median its historical median of 19.80.
Is Quipt Home Medical's 3-Year EBITDA Growth Rate too high?
Quipt Home Medical's current 3-Year EBITDA Growth Rate of 13.00% is 34% below median its 10-year median of 19.80. The Medical Distribution industry median 3-Year EBITDA Growth Rate is 6.10. Quipt Home Medical's value of 13.00% is 113.1% above this industry median. Overall, Quipt Home Medical has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Quipt Home Medical's 3-Year EBITDA Growth Rate compare to ACH and EDAP?
Quipt Home Medical's 3-Year EBITDA Growth Rate of 13.00% can be compared against companies in the Medical Distribution industry. The industry median 3-Year EBITDA Growth Rate is 6.10. Quipt Home Medical's value of 13.00% is 113.1% above this benchmark. While the company's 10-year median is 19.80 vs. the industry median of 6.10, Quipt Home Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Distribution company?
The median 3-Year EBITDA Growth Rate among Medical Distribution companies is 6.10, based on 107 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quipt Home Medical's current 3-Year EBITDA Growth Rate of 13.00% is 113.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Quipt Home Medical and its competitors. For the Medical Distribution industry, the median 3-Year EBITDA Growth Rate is 6.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quipt Home Medical's current 3-Year EBITDA Growth Rate is 13.00%, which is 34% below median its own 10-year median of 19.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quipt Home Medical stock overvalued right now?
Quipt Home Medical (QIPT) has a current 3-Year EBITDA Growth Rate of 13.00%. The stock's GF Value™ is $3.77, compared to a current price of $3.65 — trading 3.2% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 13.00%, which is 34% below median its 10-year median of 19.80 and 113.1% above the Medical Distribution industry median of 6.10. Quipt Home Medical's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Quipt Home Medical (QIPT), the current 3-Year EBITDA Growth Rate is 13.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Quipt Home Medical (QIPT) Overvalued in 2026?
Based on GuruFocus' analysis, Quipt Home Medical stock appears to be undervalued.
The current stock price of $3.65 is trading 3.2% below its estimated GF Value™ of $3.77.
Key valuation signals for QIPT:
3-Year EBITDA Growth Rate: 13.00% (34% below median its 10-year median of 19.80)
GF Value™: $3.77 vs. price of $3.65 (3.2% below fair value)
Industry Position: 113.1% above the Medical Distribution median
No single metric tells the full story. See the QIPT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quipt Home Medical Corp is a provider of durable medical equipment (DME) and home medical equipment (HME) in the United States. The Company specializes in delivering in-home treatments for the management of chronic conditions, with a primary focus on respiratory diseases, and supports patients with heart and pulmonary diseases, sleep apnea, reduced mobility, and other chronic health challenges. Its products and services include Sleep Apnea and PAP treatment, home medical equipment, home ventilation, and custom mobility solutions. The Company operates in a single business segment, comprising the sale and rental of medical equipment and related devices, and serves patients across 27 states in the United States.
62GF Score
Get the complete analysis for QIPT
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
QIPT has been successfully added to your 
